Indications for use, specifying the target species
For active immunisation of clinically healthy pigs from 17 days of age until the end of fattening and older from farms affected with European (genotype 1) Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) to reduce virus load in blood in seropositive animals under field conditions.
Under experimental challenge conditions in which only seronegative animals were included, it was demonstrated that vaccination reduces lung lesions, virus load in blood and lung tissues as well as negative effects of infection on daily weight gain. A significant reduction of the respiratory clinical signs could additionally be demonstrated at the onset of immunity.
Onset of immunity: 3 weeks
Duration of immunity: 26 weeks
injectable suspension for pigs
injectable suspension for swin
injectable suspension for pigs
Attenuated vaccine against rabbit myxomatosis
Vaccine against rabbit hemorrhagic disease